Legal or not, people are experimenting with psychedelics, and they might as well be informed about their decisions in a logical manner, making situations safer. Colorado-based Unlimited Sciences, a psychedelic research nonprofit, unveiled the Psychedelic Info Line, a hotline that provides callers with data-driven education and informed resources for... Read more
An Israeli national has been reported dead at the Tokyo Airport as the result of an overdose after authorities said he tried to smuggle over a kilogram of cocaine and other stimulants in his stomach. According to an article in the Mainichi, a national daily newspaper in Japan, authorities... Read more
The University of California, Berkeley (UCB) recently published a scientific brief in February regarding illegal water use for cannabis plants. Entitled “Water Use: Cannabis in Context,” the brief was conducted by individuals at the Berkeley Cannabis Research Center, which is part of the College of Environmental Science Policy &... Read more
Cannabis Investing 2024: 3 Top Marijuana Stocks To Watch
Leading Canadian Cannabis Stock Powers Through with Strong Weekly Momentum
Top Marijuana Stocks To Follow In 2024

3 Marijuana Stocks That Could Worth Your Time And Money

The post Top Marijuana Stocks To Follow In 2024 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
The DEA has rescinded a 2023 directive which previously ordered a pharmaceutical company to shutter operations after they were found to have helped perpetuate the nationwide opioid crisis. Morris & Dickson, a multi-billion dollar Big Pharma giant which has been in business since 1841 will be permitted to continue... Read more
An Iowa legislative panel this week approved a bill that sets limits on consumable hemp products sold in the state. The measure, House Study Bill 665, was approved on Wednesday by the House Public Safety Subcommittee by a vote of 2-0.  The bill, which was submitted to the state... Read more
Tuesday, Sen. Bernie Sanders (I-Vermont) issued a report slamming the U.S. prices of drugs and executive pay of three major drug manufacturers—Johnson & Johnson (J&J), Merck, and Bristol Myers Squibb—just before a Feb. 8 hearing. Thursday the CEO’s of all three drug manufacturers had to appear before a hearing... Read more
Best Cannabis REITs for Investors Watchlist In 2024
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )